Immune Management ApS: Financial statements 2022
CVR: 38726137
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Immune Management ApS (CVR 38726137) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,177 and a net result of DKK -16,738 compared with DKK -27,743 the year before. Equity in the 2022 report amounted to DKK 71,419. The solvency ratio was 83.2%.
- Gross Profit
- DKK -13,177
- Profit/Loss
- DKK -16,738
- Equity
- DKK 71,419
- Total Assets
- DKK 85,791
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13K | -17K | 71K | 0 |
| 2021 | - | -26K | -28K | 145K | 0 |
| 2020 | - | -17K | -117K | 230K | 0 |
| 2019 | - | 621K | 99K | 401K | - |
| 2018 | - | 500K | -55K | 303K | 1 |
Official annual report
Keep an eye on Immune Management ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Immune Management ApS has published its annual report for 2021. Gross profit came to DKK -26,044, and the net result was DKK -27,743.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.